Acute lymphoblastic leukaemia: open trials in Puerto Rico

• NCT03739814

  Inotuzumab Ozogamicin and Blinatumomab With or Without Ponatinib in Treating Patients With Newly Diagnosed, Recurrent, or Refractory CD22-Positive B-Lineage Acute Lymphoblastic Leukemia

  Trial Treatment · Phase 2 · National Cancer Institute (NCI)

  Centro Comprensivo de Cancer de UPR, San Juan · San Juan City Hospital, San Juan

  Registry updated 2026-10-28

• NCT06124157

  A Study Testing the Combination of Dasatinib or Imatinib to Chemotherapy Treatment With Blinatumomab for Children, Adolescents, and Young Adults With Philadelphia Chromosome Positive (Ph+) or ABL-Class Philadelphia Chromosome-Like (Ph-Like) B-cell Acute Lymphoblastic Leukemia (B-ALL)

  Trial Treatment · Phase 2 · National Cancer Institute (NCI)

  University Pediatric Hospital, San Juan

  Registry updated 2026-10-27

• NCT06317662

  Testing the Addition of the Anti-cancer Drug Venetoclax and/or the Anti-cancer Immunotherapy Blinatumomab to the Usual Chemotherapy Treatment for Infants With Newly Diagnosed KMT2A-rearranged or KMT2A-non-rearranged Leukemia

  Trial Treatment · Phase 2 · National Cancer Institute (NCI)

  University Pediatric Hospital, San Juan

  Registry updated 2026-10-27

• NCT04065399

  A Study of Revumenib in R/R Leukemias Including Those With an MLL/KMT2A Gene Rearrangement or NPM1 Mutation

  Trial Treatment · Phase 1/2 · Syndax Pharmaceuticals

  Hospital Centro Comprensivo de Cancer UPR, San Juan

  Registry updated 2026-10-09

• NCT04546399

  A Study to Compare Blinatumomab Alone to Blinatumomab With Nivolumab in Patients Diagnosed With First Relapse B-Cell Acute Lymphoblastic Leukemia (B-ALL)

  Trial Treatment · Phase 2 · National Cancer Institute (NCI)

  University Pediatric Hospital, San Juan

  Registry updated 2026-09-01

• NCT03959085

  Inotuzumab Ozogamicin and Post-Induction Chemotherapy in Treating Patients With High-Risk B-ALL, Mixed Phenotype Acute Leukemia, and B-LLy

  Trial Treatment · Phase 3 · Children's Oncology Group

  HIMA San Pablo Oncologic Hospital, Caguas · University Pediatric Hospital, San Juan

  Registry updated 2026-08-25

• NCT04726241

  The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study

  Trial Treatment · Phase 1/2 · PedAL BCU, LLC

  HIMA San Pablo Oncologic Hospital, Caguas · University Pediatric Hospital, San Juan

  Registry updated 2026-08-25

• NCT01790152

  Effects of Dexrazoxane Hydrochloride on Biomarkers Associated With Cardiomyopathy and Heart Failure After Cancer Treatment

  Research · Children's Oncology Group

  San Jorge Children's Hospital, San Juan

  Registry updated 2026-05-18

All Acute lymphoblastic leukaemia trials and the map

This page is not medical advice. Talk to your doctor before contacting a trial.

Report an error